Speed
Home-Speed
About Us
SPEED designs and develops biosensor for the diagnosis of cardiovascular diseases and pre-diabetic status. It uses 3D printing and IoT for the fabrication process. Initially the substrate is fabricated using a 3D printer and the electrode pattern on the substrate is transformed using screen printing. Subsequently, biosensor is integrated with semiconductor technology (IoT) for disease diagnosis.
- Founders: Dr. R. John Bosco Balaguru
- rjbosco@ece.sastra.edu
- Startup Domain:Healthcare
Our Work
-> To fabricate Screen Printed Electrodes (SPEs) for the development of electrochemical biosensorsfor point of care (PoC) diagnostics
-> Demand for PoC diagnostics using disposable SPEs to detect various biomarkers in blood, serum and urine samples is need of the hour
-> Low cost, low background currents, inert nature and high signal to noise ratio are major features that makes Graphene inkssuitable choice for electrochemical applications
-> The global PoC diagnostics market was valued at USD 23.98 billion in 2018 and is expected to reach USD 50.51 billion by the year 2026
